...
首页> 外文期刊>ACS Omega >Synthesis and Evaluation of Dibenzothiophene Analogues as Pin1 Inhibitors for Cervical Cancer Therapy
【24h】

Synthesis and Evaluation of Dibenzothiophene Analogues as Pin1 Inhibitors for Cervical Cancer Therapy

机译:二苯并噻吩类化合物作为Pin1抑制剂对宫颈癌治疗的合成和评价

获取原文

摘要

The peptidyl-prolyl isomerase Pin1 is correlated with the progression of cervical cancer via regulating numerous oncogenic and tumor suppressor pathways. p65 is a crucial regulator of tumorigenesis that is regulated by Pin1, and p65 signaling suppression can enhance the antitumor efficacy of doxorubicin (DOX). Here, we utilized a structural mimicry approach to synthesize a series of dibenzothiophene analogues and evaluated their ability to inhibit Pin1 activity. Compound 1a was identified as a potent Pin1 inhibitor that inhibited p65 signaling in vitro and in cervical cancer cells. Moreover, compound 1a enhanced the cytotoxicity of DOX in cervical cancer cells via reducing p65 nuclear accumulation and enhancing DOX uptake. These compounds are promising scaffolds for developing more potent Pin1 inhibitors against cervical cancer, either alone or in combination with anticancer drugs such as DOX.
机译:肽基脯氨酰异构酶Pin1通过调节多种致癌和抑癌途径与宫颈癌的进展相关。 p65是肿瘤发生的关键调节因子,受Pin1调节,而p65信号抑制可增强阿霉素(DOX)的抗肿瘤功效。在这里,我们利用结构模仿方法来合成一系列的二苯并噻吩类似物,并评估了它们抑制Pin1活性的能力。化合物1a被确定为有效的Pin1抑制剂,可在体外和宫颈癌细胞中抑制p65信号传导。此外,化合物1a通过减少p65核蓄积并增加DOX摄取,增强了宫颈癌细胞中DOX的细胞毒性。这些化合物是有前途的支架,可单独或与抗癌药物(如DOX)联合开发更有效的Pin1抑制剂来抵抗宫颈癌。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号